Dansk Pharmaceuticals India Private Limited

Dansk Pharmaceuticals India Private Limited - pharma in Faridabad, Haryana, India. FY 2026 financials & compliance.
CIN U24230HR2020PTC086501 Incorporated 02 June 2020 ROC Delhi HQ Faridabad, Haryana, India
Active Private Limited Company pharma Startup India MSME · Micro
Revenue · FY 2024
₹2.43 Cr
▲ 14% YoY
Net profit · FY 2024
₹1.1 Cr
Net margin 45.2%
EBITDA · FY 2024
₹1.63 Cr
EBITDA margin 67.3%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Satisfied charges
₹52.46 Lakh
No open charges
Company age
6 yrs
Est. 2020
Directors on board
5
As per MCA filings

About Dansk Pharmaceuticals India Private Limited

Data last updated:

Dansk Pharmaceuticals India Private Limited is a private limited company based in Faridabad, Haryana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 June 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230HR2020PTC086501. Its GSTIN is 09AAHCD7582L1ZY (Uttar Pradesh).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Ravipal Singh Rulania and Harinder Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 2469/D Sector – 64 Faridabad, Haryana, India – 121004.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.43 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Cr (net margin 45.2%) and EBITDA of ₹1.63 Cr (EBITDA margin 67.3%). Revenue has grown at a compounded annual rate (CAGR) of 387% over three years.

As per MCA filings, the company has satisfied charges of ₹52.46 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.

Dansk Pharmaceuticals India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0004012).

Company details

CIN U24230HR2020PTC086501
Registration Number 086501
Incorporation Date 02 June 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-HR-03-0004012

Recognitions & Rankings of Dansk Pharmaceuticals India

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-03-0004012

Contact details

Dansk Pharmaceuticals India Private Limited's registered office is in Faridabad, Haryana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    House No. 2469/D Sector – 64 Faridabad, Haryana, India – 121004
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dansk Pharmaceuticals India Private Limited, buy the company report.

Comprehensive company report
Dansk Pharmaceuticals India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Dansk Pharmaceuticals India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Dansk Pharmaceuticals India Private Limited, buy the company report.

Financials of Dansk Pharmaceuticals India Private Limited

FY 2025 filings available

Dansk Pharmaceuticals India Private Limited reported revenue of ₹2.43 Cr (up 14% YoY) for FY 2024.

Revenue · FY 2024
₹2.43 Cr ▲ 14%
Net profit · FY 2024
₹1.1 Cr margin 45.2%
EBITDA · FY 2024
₹1.63 Cr margin 67.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 387%
EBITDA CAGR growth
1 year
▲ 79%
3 years · compounded
▲ 102%

Revenue has grown at a compounded annual rate (CAGR) of 387% over three years, including 14% growth in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.63 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.1 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin67.3%
Net Profit Margin45.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dansk Pharmaceuticals India Private Limited, buy the company report.

Board of directors of Dansk Pharmaceuticals India Private Limited

Dansk Pharmaceuticals India has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ravipal Singh RulaniaDirector09 Apr 20251 Years 7 MonthsCurrent
Harinder SinghDirector01 Feb 20215 Years 9 MonthsCurrent
Sunil KumarDirector02 Jun 20206 Years 5 MonthsCurrent
Kuldeep SangwanDirector02 Jun 20206 Years 5 MonthsCurrent
Bhagat SinghDirector15 May 20224 Years 6 MonthsCurrent

Shareholding

The shareholding of Dansk Pharmaceuticals India Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Dansk Pharmaceuticals India Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹52.46 Lakh
Breakdown by lending institutions
Others₹0.52 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Mar 2022100553451Others₹52.46 LakhSatisfied

To see the full charge records of Dansk Pharmaceuticals India Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dansk Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Dansk Pharmaceuticals India Private Limited has 1 active EPFO establishment as of Nov 19, 2026.

Active EPFO establishments
1

GST

Dansk Pharmaceuticals India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAHCD7582L1ZYUttar PradeshActive31 Jul 2020

To see the full GST registrations and return filing status of Dansk Pharmaceuticals India Private Limited, buy the company report.

Recent activity

Dansk Pharmaceuticals India Private Limited has 11 board changes on record since 2020: 6 appointments and 5 cessations. The latest: Renu Kumar ceased to be Director on 12 Apr 2025.

AGM
Dansk Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Renu Kumar ceased to be Director.
Appointed
Ravipal Singh Rulania was appointed as Director.
Filing
Dansk Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Gautam Gupta ceased to be Director.
Appointed
Renu Kumar was appointed as Director.
Charges
A charge registered on 25 Mar 2022 via Charge ID 100553451 with Others was fully satisfied on 22 Jan 2024.
Ceased
Bhagat Singh ceased to be Additional Director.
Appointed
Bhagat Singh was appointed as Director.
Charges
A charge with Others amounted to Rs. 52.46 Lakh with Charge ID 100553451 was registered on 25 Mar 2022.
Ceased
Harinder Singh ceased to be Additional Director.
Ceased
Urmila Pandey ceased to be Additional Director.

4 earlier events are in the company report.

Frequently asked questions

Dansk Pharmaceuticals India is an active private limited company based in Faridabad, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 June 2020 (6+ years old) and is registered under CIN U24230HR2020PTC086501.

Dansk Pharmaceuticals India has 5 current directors:

The latest financial statements of Dansk Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Dansk Pharmaceuticals India is 09AAHCD7582L1ZY, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Dansk Pharmaceuticals India is U24230HR2020PTC086501. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dansk Pharmaceuticals India has 1 court case on record: 1 filed against it.

Dansk Pharmaceuticals India was incorporated on 02 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

Renu Kumar ceased to be Director on 12 Apr 2025. Ravipal Singh Rulania was appointed as Director on 09 Apr 2025. Gautam Gupta ceased to be Director on 08 Oct 2024. Dansk Pharmaceuticals India has 11 board changes on record in total.

Yes, Dansk Pharmaceuticals India is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Dansk Pharmaceuticals India is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-03-0004012).